Cabinet approves the MoU on Cooperation between India and Iran in the field of Traditional Systems of Medicine
A two-week-long intensive training programme on trends and challenges in regulation and standarisation of herbal drugs and formulations commenced today at NIPER here.
As many as 16 participants from 11 countries, including Afghanistan, Bhutan, Democratic Republic of Congo, Egypt, Ethiopia, Iraq, Sri Lanka, Tanzania, Trinidad and Tobago and Uzbekistan, are participating in this event, which is being sponsored by the Ministry of External Affairs.
"The global market of herbal drugs at present is USD 75 billion, which is set to touch 100 billion by 2024. However, India is contribution is just one per cent in the global market," Jachak said, adding that a lot of work is being done in nutraceuticals sector in the country.
Stressing on courses for herbal drugs and formulations, Jachak said the use of traditional medicines (TM) and complementary and alternative medicines (CAM) has seen an upsurge in both developed and developing countries.
The major concern of health authorities and the public is the safety and efficacy, as well as the quality control, of these medicines, which is a huge challenge, he said.
"These challenges are related to regulatory status, assessment of safety and efficacy, quality control, safety monitoring and lack of knowledge about TM/CAM within national drug regulatory authorities," said Jachak.
The proposed course aims at creating a platform for discussing issues related to herbal drugs worldwide and in the process impart knowledge about recent developments in the ever changing dynamics of herbal drugs and their formulations.
It also aims at promoting rational development of herbal drug products.
The course on herbal regulation and standardisation is essential for the establishing the herbal products' market for the benefit of society.
Akkinepally said the training programme, which was being conducted at NIPER, was part of the capacity building exercise.
The biggest challenge before herbal products was the regulation, he stressed.
Nine resource persons from the pharmaceutical industry, academia and regulatory agencies will deliver lectures and participate in the deliberations.
Six sessions will be held on hands on training experience on different analytical instruments.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)